Abstract:BackgroundGenome-wide association (GWA) using large numbers of single nucleotide polymorphisms (SNPs) is now a powerful, state-of-the-art approach to mapping human disease genes. When a GWA study detects association between a SNP and the disease, this signal usually represents association with a set of several highly correlated SNPs in strong linkage disequilibrium. The challenge we address is to distinguish among these correlated loci to highlight potential functional variants and prioritize them for follow-up.ResultsWe implemented a systematic method for testing association across diverse population samples having differing histories and LD patterns, using a logistic regression framework. The hypothesis is that important underlying biological mechanisms are shared across human populations, and we can filter correlated variants by testing for heterogeneity of genetic effects in different population samples. This approach formalizes the descriptive comparison of p-values that has typified similar cross-population fine-mapping studies to date. We applied this method to correlated SNPs in the cholinergic nicotinic receptor gene cluster CHRNA5-CHRNA3-CHRNB4, in a case-control study of cocaine dependence composed of 504 European-American and 583 African-American samples. Of the 10 SNPs genotyped in the r2 ≥ 0.8 bin for rs16969968, three demonstrated significant cross-population heterogeneity and are filtered from priority follow-up; the remaining SNPs include rs16969968 (heterogeneity p = 0.75). Though the power to filter out rs16969968 is reduced due to the difference in allele frequency in the two groups, the results nevertheless focus attention on a smaller group of SNPs that includes the non-synonymous SNP rs16969968, which retains a similar effect size (odds ratio) across both population samples.ConclusionFiltering out SNPs that demonstrate cross-population heterogeneity enriches for variants more likely to be important and causative. Our approach provides an important and effective tool to help interpret results from the many GWA studies now underway.

Conjuring SNPs to detect associations

Novel Association Strategy with Copy Number Variation for Identifying New Risk Loci of Human Diseases

Genome-wide association testing beyond SNPs

Beyond guilty by association at scale: searching for causal variants on the basis of genome-wide summary statistics

On Combining Data From Genome-Wide Association Studies to Discover Disease-Associated SNPs

Analysis of Case-Control Association Studies: SNPs, Imputation and Haplotypes

Model-based clustering for identifying disease-associated SNPs in case-control genome-wide association studies

Identifying Disease Associations Via Genome-Wide Association Studies

Genome-wide association studies with high-dimensional phenotypes

Implication of Next-Generation Sequencing on Association Studies

Identifying Disease-Associated Snp Clusters Via Contiguous Outlier Detection

Integrative Analysis of Sequencing and Array Genotype Data for Discovering Disease Associations with Rare Mutations

Combinatorial Search Methods for Multi-Snp Disease Association.

Simultaneous Detection of Signal Regions Using Quadratic Scan Statistics With Applications to Whole Genome Association Studies

A high-dimensional omnibus test for set-based association analysis

Searching Genome-Wide Multi-Locus Associations for Multiple Diseases Based on Bayesian Inference.

1000 Genomes-based imputation identifies novel and refined associations for the Wellcome Trust Case Control Consortium phase 1 Data

Genome-Wide Conditional Search for Epistatic Disease-Predisposing Variants in Human Association Studies

Statistical Testing of Shared Genetic Control for Potentially Related Traits

In search of causal variants: refining disease association signals using cross-population contrasts

Statistical advances and challenges for analyzing correlated high dimensional SNP data in genomic study for complex diseases